Pfizer
Director, Value and Evidence, COVID Antivirals
Pfizer, Headquarters, Idaho, United States,
Director, Value and Evidence, COVID AntiviralsApply
Locations:
United States - New York - New York City, Europe - Any Pfizer Site, United States - Pennsylvania - Collegeville, United States - California - San Francisco, United States - Florida - Tampa
Time Type:
Full time
Posted On:
Posted 3 Days Ago
Job Requisition ID:
4923392
ROLE SUMMARY
The
Director, HTA, Value & Evidence (HV&E) – Antivirals
will support the strategic goals of the Primary Care Division by driving optimal patient access for Antiviral medicines. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our Antiviral medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.
This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will manage health economics and outcomes research (HEOR) to generate data to support patient access to Antiviral medicines, focusing on pipeline Antiviral assets. Flexibility is expected to meet the evolving needs of the antiviral franchise. This position will work closely with the Antiviral GAV, cross-functional, and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and healthcare.
ROLE RESPONSIBILITIES
Lead the development of the evidence generation strategy to support the value of Antiviral pipeline assets in the Primary Care Division in close partnership with the cross-functional matrix team.
Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.
Lead the design and execution of global HEOR studies (e.g., economic models, network meta-analyses, non-interventional studies) from concept through publication.
Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.
Lead the timely development of launch deliverables including value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
Partner with internal stakeholders to ensure appropriate customer-facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
Develop strategic partnerships and research collaborations with key external experts, healthcare policymakers, payers, and various academic and community Antiviral settings to support asset strategies.
BASIC QUALIFICATIONS
Graduate degree minimum required (e.g. MSc, MPH, PhD)
9+ years of experience required with MSc/MPH/MBA degree; 7+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
Demonstrated in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies.
Knowledge and understanding of the drug development process.
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers.
Excellent oral and written English communication skills.
Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly.
Strong project management abilities (contracting, budgeting, vendor management) essential.
Ability to influence key members of medical, clinical, and commercial teams constructively.
Organized and detail-oriented with the ability to anticipate needs and work proactively.
Change-oriented, comfortable responding to unexpected demands with tight timelines; team player.
PREFERRED QUALIFICATIONS
Knowledge and experience in the Infectious Disease therapeutic area.
Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups.
Other Job Details:
Last Date to Apply for Job:
November 12th, 2024.
Position is hybrid and will require working from site 2 to 3 days per week.
NOT Eligible for Relocation Package.
Ability to travel domestically and internationally based on business needs.
The annual base salary for this position ranges from $161,600.00 to $269,400.00.* In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share-based long-term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.
About UsPfizer careers are like no other. In our culture of individual ownership, we believe in our ability to improve future healthcare, and potential to transform millions of lives. We’re looking for new talent to join our global community, to unearth new innovative therapies that make the world a healthier place.
#J-18808-Ljbffr
Locations:
United States - New York - New York City, Europe - Any Pfizer Site, United States - Pennsylvania - Collegeville, United States - California - San Francisco, United States - Florida - Tampa
Time Type:
Full time
Posted On:
Posted 3 Days Ago
Job Requisition ID:
4923392
ROLE SUMMARY
The
Director, HTA, Value & Evidence (HV&E) – Antivirals
will support the strategic goals of the Primary Care Division by driving optimal patient access for Antiviral medicines. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our Antiviral medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.
This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will manage health economics and outcomes research (HEOR) to generate data to support patient access to Antiviral medicines, focusing on pipeline Antiviral assets. Flexibility is expected to meet the evolving needs of the antiviral franchise. This position will work closely with the Antiviral GAV, cross-functional, and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and healthcare.
ROLE RESPONSIBILITIES
Lead the development of the evidence generation strategy to support the value of Antiviral pipeline assets in the Primary Care Division in close partnership with the cross-functional matrix team.
Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.
Lead the design and execution of global HEOR studies (e.g., economic models, network meta-analyses, non-interventional studies) from concept through publication.
Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.
Lead the timely development of launch deliverables including value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
Partner with internal stakeholders to ensure appropriate customer-facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
Develop strategic partnerships and research collaborations with key external experts, healthcare policymakers, payers, and various academic and community Antiviral settings to support asset strategies.
BASIC QUALIFICATIONS
Graduate degree minimum required (e.g. MSc, MPH, PhD)
9+ years of experience required with MSc/MPH/MBA degree; 7+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
Demonstrated in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies.
Knowledge and understanding of the drug development process.
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers.
Excellent oral and written English communication skills.
Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly.
Strong project management abilities (contracting, budgeting, vendor management) essential.
Ability to influence key members of medical, clinical, and commercial teams constructively.
Organized and detail-oriented with the ability to anticipate needs and work proactively.
Change-oriented, comfortable responding to unexpected demands with tight timelines; team player.
PREFERRED QUALIFICATIONS
Knowledge and experience in the Infectious Disease therapeutic area.
Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups.
Other Job Details:
Last Date to Apply for Job:
November 12th, 2024.
Position is hybrid and will require working from site 2 to 3 days per week.
NOT Eligible for Relocation Package.
Ability to travel domestically and internationally based on business needs.
The annual base salary for this position ranges from $161,600.00 to $269,400.00.* In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share-based long-term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.
About UsPfizer careers are like no other. In our culture of individual ownership, we believe in our ability to improve future healthcare, and potential to transform millions of lives. We’re looking for new talent to join our global community, to unearth new innovative therapies that make the world a healthier place.
#J-18808-Ljbffr